Home » Topics » Conferences

Conferences
RSS

Transdermal selegiline as monotherapy in mild to moderate Parkinson's disease

Oct. 26, 1998

Transdermal D2 agonist therapy with N-0923 safe and effective in PD

Oct. 26, 1998

Glycolipid derivative shows cardioprotective activity in animal models

Oct. 26, 1998

Platelet collagen receptors targeted for development of new antiplatelet therapies

Oct. 23, 1998

Botulinum toxin type F useful in type A-resistant patients with dystonia

Oct. 23, 1998

Effects of DX-9065a on platelet activation reported at international congress

Oct. 23, 1998

Efficacy and safety demonstrated for rasagiline as adjunct to levodopa in PD

Oct. 23, 1998

Xenotransplanted human dopaminergic cells improve motor deficits in MPTP-treated monkeys

Oct. 23, 1998

Role of neuromelanin in neuronal damage

Oct. 22, 1998

Fexofenadine in the treatment of chronic idiopathic urticaria

Oct. 22, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...